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Background: Traditional drug discovery approaches are mainly relied on the observed phenotypic changes
following administration of a plant extract, drug candidate or natural product. Recently, target-based approaches
are becoming more popular. The present study aimed to identify the cellular targets of crocin, the bioactive dietary
carotenoid present in saffron, using an affinity-based method.
Methods: Heart, kidney and brain tissues of BALB/c mice were homogenized and extracted for the experiments.
Target deconvolution was carried out by first passing cell lysate through an affinity column prepared by covalently
attaching crocin to agarose beads. Isolated proteins were separated on a 2D gel, trypsinized in situ and identified
by MALDI-TOF/TOF mass spectrometry. MASCOT search engine was used to analyze Mass Data.
Results: Part of proteome that physically interacts with crocin was found to consist of beta-actin-like protein 2,
cytochrome b-c1 complex subunit 1, ATP synthase subunit beta, tubulin beta-3 chain, tubulin beta-6 chain, 14-3-3
protein beta/alpha, V-type proton ATPase catalytic subunitA, 60 kDa heat shock protein, creatine kinase b-type,
peroxiredoxin-2, cytochrome b-c1 complex subunit 2, acetyl-coA acetyltransferase, cytochrome c1, proteasome
subunit alpha type-6 and proteasome subunit alpha type-4.
Conclusion: The present findings revealed that crocin physically binds to a wide range of cellular proteins such as
structural proteins, membrane transporters, and enzymes involved in ATP and redox homeostasis and signal
transduction.
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ElectrophoresisIntroduction
Dried stigma of Crocus sativus L. (Iridaceae), called saf-
fron, is a widely used dietary spice and food colorant [1].
Aside from culinary purposes, saffron has been used in
several traditional systems of medicine for the treatment
of numerous diseases such as cough, colic, insomnia,
chronic uterine hemorrhage, cardiovascular disorders
and tumors [2].
Crocin (Figure 1) is a bioactive carotenoid present in
C. sativus, and is responsible for the golden-yellow color
of saffron [3]. Modern scientific investigations have un-
veiled several interesting pharmacological activities for* Correspondence: abnouskh@mums.ac.ir
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distribution, and reproduction in any mediumcrocin including, but not limited to, antitumor [2], radical
scavenging [4], antidepressant [5] and memory-enhancing
effects [6]. In addition, crocin has been shown to possess
high antioxidant and anti-proliferative capacities in both
in-vitro and in-vivo conditions [7-11]. Yet, it must be
taken into accurate account that the anti-tumor properties
of crocin, like some other phytochemicals, are likely to be
independent of the well-known antioxidant actions. The
notion of antioxidants as potential anti-cancer agents has
recently been questioned due to some observations on the
lack of efficacy of antioxidant therapy in the treatment of
cancer [12]. Besides, it is known that some chemotherapy
agents exert their cytotoxic effects via induction of oxi-
dative stress [13]. Finally, the fact that crocin induces
apoptosis in cancerous cells – a phenomonen usually as-
sociated with increased generationof free radicals – isentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Chemical structure of crocin.
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dant and anti-cancer properties of this compound [14,15].
It has been hypothesized that phytochemicals with dual
antioxidant/anti-cancer properties may exert the latter ef-
fect via epigenetic mechanisms including promotion of
DNA demethylation, histone modification and RNA inter-
ference [16,17]. However, unraveling the mechanisms
underlying the antioxidant and anti-cancer properties of
crocin is warranted for further clarification in this context.
Moreover, dose-effect studies need to be undertaken in
order to identify optimal doses at which antioxidant and
anti-cancer effects of crocin predominate.
In spite of proven benefits, molecular mechanisms that
account for the pharmacological effects of crocin have
remained largely unknown. However, several lines of evi-
dence have demonstrated that phytochemicals promote
their biological and health promoting effects through
interaction with a variety of structural and functional
proteins [18].
Traditional approach toward drug discovery has been
mainly based on the observation of a phenotypic change
following application of a plant extract, drug candidate
or a natural product. Recently, target-based approaches
are becoming more popular. The identification of target
proteins for newly developed drugs or natural productsis regarded as "target deconvolution" [19,20]. Such an
identification of the potential targets of a small pharma-
cologically active molecule helps elucidating the primary
mechanism of action, prediction of side effects and un-
wanted off-target interactions, and finding new potential
therapeutic effects.
The present study hypothesized that pharmacological
activities of crocin depend, at least in part, on its phys-
ical interaction with cellular proteins. Hence, part of the
cellular proteome that binds to crocin was isolated from
tissue lysates using affinity chromatography and sub-
jected to mass specterometry (MS)-based proteomic
analysis to identify the potential molecular targets of this
phytochemical.Material and methods
Crocin extraction and purification
Stigmas of C. sativus L. were collected from Ghaen,
Khorasan province, Northeast of Iran, and provided by
Novin Saffron Co. (Mashhad, Iran). Analysis and quality
control of samples was conducted in accordance to the
ISO/TS 3632–2 standards. Extraction and purification of
crocin from saffron was carried out as previously de-
scribed by Hadizadeh and colleagues [21].
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Twelve BALB/c mice (20–25 g) were killed by decapita-
tion. Heart, kidney and brain tissues of mice were col-
lected and washed using 0.9% normal saline solution.
Tissues were immediately frozen in liquid nitrogen and
transferred to −80°C until use. All animal experiments
were carried out in accordance with the acts of the
Mashhad University of Medical Sciences Ethics Committee
(code 87772).
Preparation of tissue extracts
Each sample (200–400 mg) was homogenized 1:5 (w:v) in
extraction buffer containing 50 mM Tris (pH 7.4), 2 mM
EGTA, 2 mM EDTA, 2 mM Na3VO4,, 1% Triton X-100
and 10 mM 2-mercaptoethanol with further addition of
a few crystals of the protease inhibitor, phenylmethylsulfo-
nyl fluoride (PMSF) immediately before homogeniza-
tion of tissue. Samples were homogenized using a
Polytron Homogenizer (Kinematica, Switzerland) for
10 sec followed by sonication (UP100H, Hielscher) for 40
sec and centrifugation (Hettich Universal 320R, Germany)
at 25,000 g for 10 min at 4°C. The supernatant was then
removed and stored on ice. Protein contents were mea-
sured using Bradford protein assay (BioRad). The protein
contents of all samples were adjusted to 2 mg/mL.
Preparation of crocin-resin conjugate
Crocin affinity matrix was prepared using pharmaLink
Kit (Pierce) according to the manufacturer’s instructions.
Briefly, agarose beads containing immobilized diamino-
dipropylamine (DADPA) were equilibrated in 4 mL
coupling buffer (0.1 M MES, 0.15 M NaCl, pH 4.7). Cro-
cin (100 mg) was dissolved in 2 mL of coupling buffer
and transferred to the aforementioned resin slurry.
Coupling reaction was started by adding 200 μL of coup-
ling reagent (37% formaldehyde solution) to the resin/
crocin mixture. Reaction mixture was incubated for 72 h
in 50°C. To remove free crocin, resin slurry was trans-
ferred to a column and washed 12 times each time with
2 mL of wash buffer (0.1 M Tris, pH 8.0). Flowthrough
fractions were collected and pooled. Quantity of free
crocin was calculated by measuring absorbance of
pooled flowthrough fractions at 441.6 nm using visible
spectroscopy (CECIL 9000 Series). Efficiency of crocin
conjugation to resin was calculated using the following
equation:
% Resin−conjugated crocin ¼ mg totatl crocinð Þ−mg free crocinð Þ
mg total crocinð Þ
Affinity chromatography
Affinity chromatography was performed to isolate mo-
lecular targets of crocin. Briefly, both controlss (affinity
column without crocin) and affinity column wereequilibrated in binding buffer [50 mM Tris (pH 7.4), 2
mM EGTA, 2 mM EDTA, 2 mM Na3VO4,, 1% Triton X-
100, and 10 mM 2-ME]. Tissue extracts were incubated
with control column resin for 30 min at 4°C. After a brief
centrifugation at 1000 g, supernatants were transferred to
the affinity column. Following incubation for 30 min at
4°C, affinity column was washed 4 times each time with 2
mL of binding buffer. Crocin target proteins were eluted
using 2 mL of 2 M NaCl in binding buffer. The elution
was repeated 3 more times and fractions were pooled. The
presence of proteins in fractions was tested using Bradford
protein assay kit (BioRad). The pooled fractions were dia-
lyzed at a 2000 Da cut-off to remove electrolytes. To con-
centrate target proteins, samples were freeze-dried and
stored at −20°C until use.
2D gel electrophoresis
Freeze-dried samples were dissolved to a final concentra-
tion of 125 μg/125 μL in rehydration buffer containing
6 M urea, 2 M thiourea, 2% (3-[(3-Cholamidopropyl)-
dimethylammonio]-1-propane sulfonate) (CHAPS), 50
mM dithiothreitol (DTT) and 20% Bio-Lyte (BioRad).
Non-linear immobilized pH gradients (IPGs) (pH 3–10;
BioRad) were used to separate crocin target proteins based
on their isoelectric point [1]. For passive rehydration, IPGs
and protein solutions were incubated at room temperature
for 12 h. Isoelectric focusing was performed using PRO-
TEAN IEF cell (BioRad) at 4000 V for 11 h. After isoelec-
tric focusing, IPGs were incubated in equilibration buffer
[375 mM Tris (pH 8.8), 6 M Urea, 2.5% SDS and 30% gly-
cerol] for 20 min. Then, IPGs were placed on top of 12%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and sealed with heated agarose solution (25
mM Tris (pH 8.8), 84 mM glycine, 0.5% agarose, 0.1%
SDS and small amount of tracking dye bromophenol
blue). Electrophoresis was performed for 80 min at 120 V.
Gels were silver stained and protein spots were excised
and collected in microtubes.
In-gel digestion
Gel slices were incubated in destaining buffer (50%
MeOH, 5% acetic acid) overnight at room temperature.
Destaining was repeated with fresh buffer for 2 more h.
Gel slices were dehydrated in acetonitrile for 30 min and
dried in vacufuge. Afterwards, gels were covered with re-
ducing buffer (1.5 mg/mL DTT in 100 mM ammonium
bicarbonate) for 1 h. Protein alkylation was performed
by incubation of gel slices in 100 μL of 10 mg/mL iodoa-
cetamide in 100 mM ammonium bicarbonate for 30 min
at room temperature. Gel slices were washed using 0.5
mL of 100 mM ammonium bicarbonate followed by de-
hydration using acetonitrile and drying in vacufuge.
Then, 50 μL of 20 μg/mL trypsin was added to each gel
slice and incubated overnight at 4°C. Peptides were
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monium bicarbonate, 100 μL extraction solution (50%
acetonitrile and 5% formic acid) and finally 150 μL ex-
traction solution. Samples were dried down to a final
volume of 15 μL in vacufuge and desalted using ZipTip®
μC-18 (Millipore). Eluted samples were stored at −20°C
until use.
Mass analysis
Mass analysis was performed at Genome Research
Centre at the University of Hong Kong using a 4800
MALDI-TOF/TOF analyzer (ABI). In-house MASCOT
search engine was used to analyze Mass Data. Data were
BLASTed against both NCBInr and SwissProt databases.
MASCOT parameters were set as follow: Taxonomy:
mouse, fixed modification: carbamidomethyl (C), vari-
able modification: oxidation (M), MS/MS fragment tol-
erance: 0.2 Da, precursor tolerance: 75 ppm, peptide
charge: +1, monoisotopic. MASCOT cut-off scores were
set to 30. Only the peptides ranked first with p-values
smaller than 0.05 were accepted.
Results
Affinity chromatography was performed to find cellular
targets of crocin in different organs. There are two types
of interactions between stationary phase and cellular
proteins in affinity chromatography: specific interactionFigure 2 A schematic summary of study design and methodology.between crocin and its targets or unspecific binding of
proteins to other parts of stationary phase such as agar-
ose beads. To reduce unspecific binding of non-target
proteins, tissue extracts were incubated with control
agarose beads. Unbound proteins were incubated with
crocin-resin beads. Target proteins were eluted using 2
M NaCl in binding buffer and subjected to 2D gel elec-
trophoresis. After in-gel digestion of protein spots,
MALDI TOF/TOF was employed for their identification.
Mass data were analyzed using MASCOT (Figure 2;
Additional file 1).
Crocin-resin conjugation
Crocin was covalently attached to diaminodipropyla-
mine side chain of agarose beads using Mannich reac-
tion. Briefly, formaldehyde reacts with primary amino
group to produce highly reactive iminium group. This
group can react with active hydrogen on hydroxyl
groups of sugar residues on crocin. Yield of crocin con-
jugation to agarose beads was calculated to be 70%. In
FT-IR spectrum of crocin-resin conjugate, hydroxyl
groups (−OH) of crocin glycosides were observed at
3410.06 cm-1 which is identical with that of pure crocin
(Figure 3). Besides other peaks in the crocin-resin con-
jugate were overlapped with those of pure crocin, sug-
gesting the presence of crocin with its functional groups
within the conjugate.
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Beta-actin-like protein 2, cytochrome c1, proteasome
subunit alpha type-6 and proteasome subunit alpha
type-4 were identified as cellular targets of crocin in
kidney (Figure 4 and Table 1).
Target proteins of crocin in heart
Data indicated that crocin binds to mitochondrial ATP
synthase subunit beta, beta-actin-like protein 2, cyto-
chrome b-c1 complex subunit 1 and subunit 2, and
acetyl-CoA acetyltransferase in heart (Figure 5 and
Table 1).
Target proteins of crocin in Brain
Target proteins of crocin in brain were identified as
tubulin beta-3 chain, tubulin beta-6 chain, mitochondrial
ATP synthase, beta-actin-like protein 2, 14-3-3 protein
beta/alpha, tyrosine 3-monooxygenase, V-type proton
ATPase catalytic subunit A, 60 kDa heat shock protein,
creatine kinase B-type and peroxiredoxin-2 (Figure 6
and Table 1).
Discussion
Saffron has been mentioned in the folk medicine to
have a warm and dry temperament [22]. This plant is
endowed with a variety of health benefits including
exhilarant, liver tonic and deobstruent, aphrodisiac,
labour-inducing, emmenagogue, digestive, hypnotic, cardi-
oprotective, anti-inflammatory and bronchodilatory prop-
erties [22,23]. Interestingly, most of these traditional uses
are consistent with the findings of modern pharmaco-
logical research [23].
In the present study, affinity purification was exploited
to identify cellular proteins that could physically interact
with crocin. This technique has a distinct superiority toFigure 3 FT-IR spectrum of crocin (red) and crocin-resin conjugate (grother deconvolution methods such as biochemical frac-
tionation, phage display and expression cloning as it is
more relevant to be used with crude cellular samples in
which the proteins are in their intact biological form [24].
Drugs are normally discovered based on their ability
to show a certain desired biological outcome. For in-
stance, crude natural product mixtures are tested for a
specific pharmacological activity and then active ingredi-
ent is purified. The retrospective identification of the
molecular targets that underlie the observed phenotypic
responses is called target deconvolution. Unveiling the
cellular targets of a given molecular entity is necessary
for a better understanding of its mechanism of action,
prediction of potential pharmacological activities as well
as plausible side effects and off-target toxicities.
Affinity-based target deconvolution method is compli-
cated by the risk of identifying interactions with proteins
that have no pharmacological relevance (false positives),
despite being targets of the compound. Therefore, activity-
or phenotype-based assays are essential to discriminate
between positive and false-positive interactions and to
confirm true functional effects [19]. Another major chal-
lenge in affinity chromatography-coupled MS technology
is the non-specific interaction of proteins with the immo-
bilized support and/or linker [24]. In the current investiga-
tion, the referred problem was minimized by applying a
control column and eliminating the cellular proteins that
are more prone to bind the solid support.
Proteomic findings revealed that crocin binds to a
wide range of cellular proteins such as structural pro-
teins, membrane transporters, and enzymes involved in
ATP and redox homeostasis and signal transduction.
Beta-actin-like protein 2 was identified as one of the
target proteins of crocin. Actin filaments help maintain-
ing cell morphology and mediate functions such aseen).
Figure 4 2D gel electrophoresis of crocin targets in kidney extract. Spots were identified as Beta-actin-like protein 2, cytochrome c1,
proteasome subunit alpha type-6 and proteasome subunit alpha type-4.
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ision. Natural products like cytochalasin and jasklapi-
nolide that interact with actin polymerization have
cytotoxic effects [25].
Tubulin beta 3 and 6 are also cytoskeletal proteins that
interact with crocin. Microtubules are long, hollow, cy-
lindrical protein polymers composed of α/β-tubulin het-
erodimers. An important function of microtubules is to
move cellular structures such as chromosomes, mitotic
spindles and other organelles inside the cell [26]. Several
microtubule-inhibiting agents such as vincristine, vin-
blastine, taxol and colchicine have shown potent activity
against the proliferation of various cancer cells [27].Table 1 Target proteins of crocin as identified by MALDI-TOF
Protein name Protein score
1 Acetyl-CoA acetyltransferase 81
2 V-type proton ATPase catalytic subunitA 113
3 Proteasome subunit alpha type-4 159
4 14-3-3 protein beta/alpha 160
5 Tubulin beta-6 chain 169
6 Proteasome subunit alpha type-6 170
7 Beta-actin-like protein 2 215
8 Tubulin beta-3 chain 258
9 Cytochrome b-c1 complex subunit 1 265
10 Cytochrome c1 277
11 Peroxiredoxin-2 283
12 Cytochrome b-c1 complex subunit 2 323
13 60 kDa heat shock protein 348
14 Creatine kinase B-type 388
15 ATP synthase subunit beta 485Crocin has been reported to significantly inhibit the
growth of different types of cancerous cell lines such as
colorectal cancer cells [11]. Effects of crocin on tubulin
polymerization has been already studied [28]. Crocin
may alter the tubulin polymerization through direct
binding.
ATP synthase is a key enzyme of mitochondrial energy
conversion [29]. Ahmad and Laughlin [30] discussed
that dietary polyphenols and amphibian antimicrobial/
antitumor peptides inhibit ATP synthase. Inhibition of
ATP synthase may cause energy deprivation and increase
ROS production. High ROS content induces cellular ne-
crosis and/or apoptosis [29]. Our experiment showed/TOF and MASCOT
Protein score C.I.% MW/pI Accession number












100 61KDa/6.33 Gi 247242
100 43KDa/5.4 Q04447.1
100 56KDa/5.19 P56480.2
Figure 5 2D gel electrophoresis of crocin targets in heart extract. Spots were identified as mitochondrial ATP synthase subunit beta, beta-
actin-like protein 2, cytochrome b-c1 complex subunit 1 and subunit 2 and acetyl-CoA acetyltransferase.
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which is consistent with the findings of a previous study
with safranal as another important constituent of saffron
[31]. However, contrasting evidence has shown that cro-
cin reduces ROS generation in cells exposed to acry1a-
mide [32]. Overall, the majority of previous findings
favor the antioxidant role of crocin and this may be due
to the inhibitory effect of this phytochemical on other
sources of ROS production, in particular lipid peroxida-
tion, as well enhancement of free radical neutralization
via stimulating the activity of superoxide dismutase and
increasing intracellular glutathione content [33,34].
Creatine kinase (CK) catalyzes transfer of phosphate
group from ATP to creatine to produce phosphocreatineFigure 6 2D gel electrophoresis of crocin targets in brain extract. Spo
mitochondrial ATP synthase, beta-actin-like protein 2, 14-3-3 protein beta/a
subunit A, 60 kDa heat shock protein, creatine kinase B-type and peroxiredand vice versa. CK works as an energy buffer and is
found in tissues with high and/or fluctuating energy de-
mand such as heart, muscle and brain [35]. Incubation
of crocin-resin with brain homogenate showed that cro-
cin has affinity for CK-B. Any change in CK activity may
affect energy homeostasis in cell. Dahlstedt and Wester-
blad [36] showed that creatine kinase inhibition may re-
duce the rate of fatigue induced by decrease in tetanic
Ca2+ in mouse skeletal muscle [37]. The oral administra-
tion of crocetin (another carotenoid of saffron) has been
reported to improve physical capacity during fatigue-
induced workload tests in men [38].
Crocin was also found to interact with cytochrome c1
and cytochrome b-c1. The most conserved role of thesets were identified as tubulin beta-3 chain, tubulin beta-6 chain,
lpha, tyrosine 3-monooxygenase, V-type proton ATPase catalytic
oxin-2.
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tive phosphorylation. Moreover, cytochrome c release into
the cytosol is particularly associated with activation of the
intrinsic apoptotic pathway [39]. In previous studies, saf-
fron carotenoids including crocin have been shown to
modulate apoptosis through different mechanisms such as
inhibition of ROS production [32,33] and direct inter-
action with caspase-3 and caspase-8 [14,15]. Crocin has
been reported to promote apoptosis in tumor cells while
exerting anti-apoptotic effects in non-tumor cells [40,41].
In view of the present finding, interaction of crocin with
cytochrome c might play an important role in the stimula-
tory and inhibitory activities of this phytochemical on the
apoptosis pathway and deserves further attention.
V-ATPase inhibitors such as bafilomycin A1 may induce
apoptosis through intracellular acidosis. Effects of physical
binding of crocin on V-ATPase activity should be studied
in detail. It has been discussed that V-ATPase inhibitors
can potentially be used in the treatment of solid tumors
with overexpressed levels of this enzyme [42].
Crocin may also interact with biosynthetic pathways
through direct interaction with acetyl-coenzyme A acetyl
transferases (ACAT). ACAT converts two units of acetyl-
CoA to acetoacetyl CoA in poly beta-hydroxybutyrate syn-
thesis or steroid biogenesis [43].
Our study also showed that crocin binds to prote-
asome α type 4 and 6. Proteasome degrades misfolded
and/or ubiquitin-tagged proteins. Proteasome inhibitors,
like disulfiram, have been recently studied for cancer
therapy [44,45]. Affinity of crocin for proteasome may
explain its cytotoxic effect at higher concentrations.
Another crocin target was identified as 14-3-3 protein
beta/alpha. 14-3-3 proteins are implicated in the regula-
tion of key proteins such as Raf, bad, and Cbl, and are
implicated in various biological processes such as signal
transduction, transcriptional control, cell proliferation,
apoptosis and ion channel physiology [46]. 14-3-3 pro-
tein zeta interacts with insulin resistance substrate-1
(IRS-1) protein and might therefore play a role in regu-
lating insulin sensitivity. Crocin and safranal have been
reported to reduce blood glucose and HbA1c levels but
increase blood insulin levels significantly without any
significant effect on liver and kidney functions in
alloxan-induced diabetic rats [47].
Affinity of crocin for heat shock protein 60 may explain
some the protective effects of saffron. Heat shock proteins
are chaperones that assist proteins for proper folding, sta-
bility and transport across cellular membranes [48]. There
is evidence indicating the cardioprotective effects of saf-
fron and improvement of histopathologic and biochemical
parameters in the cardiac tissue following stress [49,50].
Overexpression of heat shock protein 60 in myocardium
is a defensive biological mechanism for the preservation of
cardiac function upon exposure to cardiotoxic agents orother stressors [51]. Physical interaction of crocin with
heat shock protein 60 might influence the function of this
chaperone and improves its protective effects.
Peroxiredoxin-2 also shows some degrees of physical
affinity to crocin. Peroxiredoxin-2 reduces the level of
H2O2 in cells. Both crocin and peroxiredoxin may play
an antioxidant protective role in cells. Physical inter-
action of these two enzymes may alter their antioxidant
capacity.
In summary, the present data revealed that tubulin beta-
3 chain, tubulin beta-6 chain, ATP synthase subunit beta,
beta-actin-like protein 2, 14-3-3 protein beta/alpha, V-type
proton ATPase, 60 kDa heat shock protein, creatine kinase
B-type, peroxiredoxin-2, cytochrome b-c1 complex, cyto-
chrome c1, heme protein, acetyl-CoA acetyltransferase,
proteasome subunit alpha type-4 and type-6, protein
disulfide-isomerase and delta-aminolevulinic acid dehy-
dratase could serve as potential cellular targets for crocin.
Although physical interaction of crocin with these proteins
may explain some of its pharmacological effects, activity-
or phenotype-based assays are essential to discriminate
between positive and false-positive interactions.
Additional file
Additional file 1: Results of MASCOT search are available as
supporting information.
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